Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease

by Karayel, O., Kuras, Y.I, Mann, M., Merchant, K., Padmanabhan, S., Scherzer, C.R, Tuncali, I., Virreira Winter, S., Vu, D.T, Wills, A.-M
Published 2022

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Pl...

by Alcalay, R.N, Cutter, G., Fischer, T.Z, Gaemers, S.J.M, Gasser, T., Giladi, N., Hatano, T., Hattori, N., Höglinger, G.U, Isaacson, S.H, Marek, K., Minini, P., Peterschmitt, M.J, Saiki, H., Sardi, S.P, Saubadu, S., Schapira, A.H.V, Scherzer, C.R, Sharma, J., Simuni, T., Walbillic, S.
Published 2022

Australian Parkinson's Genetics Study (APGS): Pilot (n=1532)

by Bivol, S., Campos, A.I, Cross, S., Ferguson, M., Garcia-Marin, L.M, Gratten, J., Lind, P.A, Loesch, D.Z, Martin, N.G, Medland, S.E, Mellick, G.D, Mitchell, B.L, Mosley, P.E, Mulcahy, A., Parker, R., Poortvliet, P.C, Rentería, M.E, Scherzer, C.R, Visscher, P.M
Published 2022